Get startedLog in
    Picture of Refocus logo

    RFCS — Refocus Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Refocus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2000
    December 31st
    2001
    December 31st
    2002
    December 31st
    2003
    December 31st
    2004
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10KSB10KSB10KSB10KSB10KSB
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1.310.23000
    Cost of Revenue
    Gross Profit0.7890.006000
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses3.794.843.085.63.69
    Operating Profit-2.47-4.61-3.08-5.6-3.69
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-2.19-4.45-3.06-5.69-3.84
    Provision for Income Taxes
    Net Income After Taxes-2.19-4.45-3.06-5.69-3.84
    Net Income Before Extraordinary Items
    Net Income-2.19-4.45-3.06-5.69-3.84
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Dilution Adjustment
    Diluted Net Income-2.63-5.07-5.86-5.7-3.84
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.374-0.748-0.889-0.338-0.164
    Dividends per Share